Literature DB >> 10425373

Relationships between the effective interparticulate contact area and the tensile strength of tablets of amorphous and crystalline lactose of varying particle size.

T Sebhatu1, G Alderborn.   

Abstract

The aim of this study was to experimentally evaluate an equation for describing tablet tensile strength by studying relationships between the measured tensile strength and the calculated effective interparticulate contact area in tablets prepared from varying size fractions of amorphous and crystalline lactose at varying pressures. Amorphous lactose produced tablets of higher tensile strength than crystalline lactose and there was a tendency for reduced particle size to increase tablet strength. The tablet tensile strength correlated reasonably well with the effective area of contact for each material after compensation for a particle size-related intercept. It was thus concluded that the tensile strength equation under investigation reflects a structural property of the tablet which correlates with the tensile strength of the tablet. The slope of the tensile strength-contact area relationship differed between the materials and original particle size also had a small effect on this parameter. The results indicate thus also that the differences in compactability between amorphous and crystalline lactose are mainly the result of differences in bonding capacity, although differences in particle deformability also play a limited part.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10425373     DOI: 10.1016/s0928-0987(99)00025-1

Source DB:  PubMed          Journal:  Eur J Pharm Sci        ISSN: 0928-0987            Impact factor:   4.384


  9 in total

1.  Spray-dried cellulose nanofibers as novel tablet excipient.

Authors:  Ruzica Kolakovic; Leena Peltonen; Timo Laaksonen; Kaisa Putkisto; Antti Laukkanen; Jouni Hirvonen
Journal:  AAPS PharmSciTech       Date:  2011-10-18       Impact factor: 3.246

2.  Predicting the tensile strength of compacted multi-component mixtures of pharmaceutical powders.

Authors:  Chuan-Yu Wu; Serena M Best; A Craig Bentham; Bruno C Hancock; William Bonfield
Journal:  Pharm Res       Date:  2006-08       Impact factor: 4.200

3.  Effect of surface energy on powder compactibility.

Authors:  Frauke Fichtner; Denny Mahlin; Ken Welch; Simon Gaisford; Göran Alderborn
Journal:  Pharm Res       Date:  2008-06-12       Impact factor: 4.200

4.  3D simulation of internal tablet strength during tableting.

Authors:  Simo Matti Siiriä; Osmo Antikainen; Jyrki Heinämäki; Jouko Yliruusi
Journal:  AAPS PharmSciTech       Date:  2011-05-04       Impact factor: 3.246

5.  Effect of polymer content and molecular weight on the morphology and heat- and moisture-induced transformations of spray-dried composite particles of amorphous lactose and poly(vinylpyrrolidone).

Authors:  Jonas Berggren; Göran Alderborn
Journal:  Pharm Res       Date:  2003-07       Impact factor: 4.200

6.  Formulation design of granules prepared by wet granulation method using a multi-functional single-punch tablet press to avoid tableting failures.

Authors:  Takashi Osamura; Yoshiko Takeuchi; Risako Onodera; Masahiro Kitamura; Yoshiteru Takahashi; Kohei Tahara; Hirofumi Takeuchi
Journal:  Asian J Pharm Sci       Date:  2017-08-10       Impact factor: 6.598

7.  Prediction of effects of punch shapes on tableting failure by using a multi-functional single-punch tablet press.

Authors:  Takashi Osamura; Yoshiko Takeuchi; Risako Onodera; Masahiro Kitamura; Yoshiteru Takahashi; Kohei Tahara; Hirofumi Takeuchi
Journal:  Asian J Pharm Sci       Date:  2017-05-17       Impact factor: 6.598

8.  Physicochemical Properties of Poly-Vinyl Polymers and Their Influence on Ketoprofen Amorphous Solid Dispersion Performance: A Polymer Selection Case Study.

Authors:  Emer Browne; Zelalem A Worku; Anne Marie Healy
Journal:  Pharmaceutics       Date:  2020-05-08       Impact factor: 6.321

9.  Atypical compaction behaviour of disordered lactose explained by a shift in type of compact fracture pattern.

Authors:  Samaneh Pazesh; Ann-Sofie Persson; Göran Alderborn
Journal:  Int J Pharm X       Date:  2019-11-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.